Circulating tumor cells (CTC) have become an important biomarker for early cancer diagnosis, prognosis, and treatment monitoring. Recently, a replication-competent recombinant adenovirus driven by a human telomerase gene (hTERT) pro-moter was shown to detect live CTCs in blood samples of patients with cancer. Here, we report a new class of adeno-viruses containing regulatory elements that repress the hTERT gene in normal cells. Compared with the virus with only the hTERT core promoter, the new viruses showed better selectivity for replication in cancer cells than in normal cells. In particular, Ad5GTSe, containing three extra copies of a repressor element, displayed a superior tropism for cancer cells among leukocytes and was thus selected ...
Current shortcomings in cancer therapy require the generation of new, broadly applicable, potent, ta...
Early detection of tumor cells by identifying universal Tumor Associated Antigens (TAA) can drastica...
Purpose: Because chemoradiotherapy selectively targets proliferating cancer cells, quiescent cancer ...
The presence of circulating tumor cells (CTCs) in the peripheral blood is associated with short surv...
As epithelial cells in the circulation are considered to originate from the tumor, the epithelial ce...
Background Molecular-based companion diagnostic tests are being used with increasing frequency to pr...
Circulating tumor cells (CTCs) are promising biomarkers in several cancers, and thus methods and app...
Circulating tumor cells (CTC) quantified in cancer patients' blood can predict disease outcome and r...
Detection of circulating tumor cells remains a significant challenge due to their vast physical and ...
Circulating tumor cell (CTC) detection and genetic analysis may complement currently available disea...
Single-cell sequencing provides promising information in tumor evolution and heterogeneity. Even wit...
Primary tumors shed thousands of cells into blood circulation every day. These circulating tumor cel...
Colorectal cancer (CRC) recurrence after curable resection is still high. This fact strongly suggest...
Current shortcomings in cancer therapy require the generation of new, broadly applicable, potent, ta...
Detection of circulating tumor cells (CTCs) in whole blood from metastatic cancer patients by the Ce...
Current shortcomings in cancer therapy require the generation of new, broadly applicable, potent, ta...
Early detection of tumor cells by identifying universal Tumor Associated Antigens (TAA) can drastica...
Purpose: Because chemoradiotherapy selectively targets proliferating cancer cells, quiescent cancer ...
The presence of circulating tumor cells (CTCs) in the peripheral blood is associated with short surv...
As epithelial cells in the circulation are considered to originate from the tumor, the epithelial ce...
Background Molecular-based companion diagnostic tests are being used with increasing frequency to pr...
Circulating tumor cells (CTCs) are promising biomarkers in several cancers, and thus methods and app...
Circulating tumor cells (CTC) quantified in cancer patients' blood can predict disease outcome and r...
Detection of circulating tumor cells remains a significant challenge due to their vast physical and ...
Circulating tumor cell (CTC) detection and genetic analysis may complement currently available disea...
Single-cell sequencing provides promising information in tumor evolution and heterogeneity. Even wit...
Primary tumors shed thousands of cells into blood circulation every day. These circulating tumor cel...
Colorectal cancer (CRC) recurrence after curable resection is still high. This fact strongly suggest...
Current shortcomings in cancer therapy require the generation of new, broadly applicable, potent, ta...
Detection of circulating tumor cells (CTCs) in whole blood from metastatic cancer patients by the Ce...
Current shortcomings in cancer therapy require the generation of new, broadly applicable, potent, ta...
Early detection of tumor cells by identifying universal Tumor Associated Antigens (TAA) can drastica...
Purpose: Because chemoradiotherapy selectively targets proliferating cancer cells, quiescent cancer ...